SCHEMBL11097547

SCHEMBL11097547

CCCCC(C)(N)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11576404 0.92 FDPS (0.46)
SCHEMBL11102665 0.90 SMPD1 (0.48)
SCHEMBL11182482 0.90 SMPD1 (0.48)
SCHEMBL11234308 0.90 SMPD1 (0.48)
SCHEMBL11235739 0.90 SMPD1 (0.48)
SCHEMBL10791301 0.85 CYP2D6 (0.39)
SCHEMBL372172 0.85 FDPS (0.44)
SCHEMBL1669837 0.82 CYP2D6 (0.37)
SCHEMBL10909327 0.82
Ammonia Solution, Strong SCHEMBL28112649 0.82 FDPS (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340141-A1 TLR8 AGONIST CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2021-11-04 US disclosed
EP-3875451-A1 TLR8 AGONIST Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-09-08 EP disclosed
EP-0001284-B1 UV-LIGHT STABILIZED COMPOSITIONS CONTAINING SUBSTITUTED 2-KETO-1,4-DIAZACYCLOALKANES The B.F. GOODRICH Company (US) 1984-05-23 EP disclosed
EP-0001559-B1 SYNTHESIS OF 2-KETO-1,4-DIAZACYCLOALKANES The B.F. GOODRICH Company (US) 1982-01-13 EP disclosed
EP-0024337-A1 Synthesis of 2-keto-1,4-diazacycloalkanes The B.F. GOODRICH Company (US) 1981-03-04 EP disclosed
EP-0001559-A2 Synthesis of 2-keto-1,4-diazacycloalkanes The B.F. GOODRICH Company (US) 1979-05-02 EP disclosed
EP-0001284-A1 UV-light stabilized compositions containing substituted 2-keto-1,4-diazacycloalkanes The B.F. GOODRICH Company (US) 1979-04-04 EP disclosed